| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fate Therapeutics Inc (FATE) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 39 sells. FATE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.89M | $8.31M | - | |
| CEO | 1.30M | $2.78M | - | |
| Other | 400.0K | $854.0K | - | |
| Dir | 110.0K | $234.8K | - | |
| CFO | 100.0K | $213.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Valamehr Bahram87 | Chief Development Officer | Sale+OE | 25,000 | $66.29 | $1,657,257.42 | -7.8% | -25.5% | -61.1% | |
| Aug 19, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 20,000 | $88.01 | $1,760,204.00 | -4.8% | -37.5% | -66.1% | |
| Aug 19, 2021 | Dulac Edward J III81 | Chief Financial Officer | Sell | 3,474 | $88.26 | $306,602.40 | -2.1% | -37.5% | -66.1% | |
| Jul 23, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 60,000 | $85.67 | $5,140,113.38 | -3.6% | -31.0% | -64.0% | |
| Jul 1, 2021 | Tahl Cindy79 | General Counsel And Secretary | Sale+OE | 55,534 | $85.24 | $4,733,743.28 | -3.1% | -36.6% | -73.3% | |
| Jun 14, 2021 | Valamehr Bahram87 | Chief Development Officer | Sale+OE | 25,000 | $89.32 | $2,233,045.21 | -7.8% | -26.9% | -79.3% | |
| May 20, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 20,000 | $77.16 | $1,543,292.00 | -4.8% | +17.8% | -70.1% | |
| Apr 23, 2021 | Wolchko J Scott87 | President And CEO | Sale+OE | 60,000 | $85.39 | $5,123,496.00 | -7.1% | +0.7% | -59.4% | |
| Apr 16, 2021 | Chu Yu-Waye72 | Senior VP Clinical Development | Sell | 3,275 | $83.30 | $272,809.00 | -1.6% | -5.5% | -56.3% | |
| Apr 1, 2021 | Tahl Cindy79 | See Remarks | Sale+OE | 30,000 | $83.81 | $2,514,329.03 | -3.0% | +6.0% | -49.6% |